CRISPR treatment delivers benefits in mice
The researchers from Duke University along with drugmaker Sarepta Therapeutics published a report stating that a single change in the genetic system of Duchenne muscular dystrophy (DMD) affected mice, using CRISPR gene editing tool resulted in increasing their life span by one year. No toxic immune responses were exhibited to Cas9 enzyme used for gene editing.
A step ahead in treating metastatic Kidney Cancer
Drug makers Merck & Co. and Pfizer conducted trials giving thumbs up to pair immunotherapy with a type of targeted drug to treat metastatic Kidney Cancer. In trials, patients who received Merck's Keytrud...
